34 results
8-K
EX-99.1
PDSB
PDS Biotechnology Corporation
4 Dec 23
Other Events
4:02pm
with or in place of current standard of care Better tolerability and less toxic alternatives to chemotherapy Significant Unmet Needs Remain in Recurrent
8-K
EX-99.1
PDSB
PDS Biotechnology Corporation
3 Oct 23
Other Events
4:03pm
be used with or in place of current standard of care Better tolerability and less toxic alternatives to chemotherapy Despite the Availability
8-K
EX-99.1
PDSB
PDS Biotechnology Corporation
11 Sep 23
Other Events
4:05pm
. Safer and more effective treatments that may be used with or in place of current standard of care Better tolerability and less toxic alternatives
8-K
EX-99.1
PDSB
PDS Biotechnology Corporation
18 Aug 23
Other Events
4:04pm
and less toxic alternatives to chemotherapy Despite the Availability of Treatments, Significant Unmet Needs Remain in Recurrent or Metastatic HNSCC
8-K
EX-99.1
4zgjeony0gxoksg 3ilj
14 Jun 23
Other Events
4:01pm
8-K
EX-99.1
sgm85z
1 Jun 23
Other Events
5:19pm
8-K
EX-99.1
f0al4ham po78o84
25 May 23
Other Events
5:02pm
8-K
EX-99.1
7zwhm aavqa
17 May 23
Other Events
4:48pm
8-K
EX-99.1
ovof zue8
27 Apr 23
Other Events
4:35pm
8-K
EX-1.1
iicx 0tpxj5lq4xzqewm
17 Jun 21
PDS Biotech Announces Proposed Offering of Common Stock
12:00am
8-K
EX-1.1
ncwx0n
13 Aug 20
PDS Biotechnology Corporation Announces Proposed Public Offering of Common Stock
4:30pm
8-K
EX-99.1
l1g2z 4i21
9 Jun 20
CORPORATE PRESENTATION Frank Bedu-Addo Ph.D. President & CEO JUNE 2020
4:30pm
8-K
EX-99.1
yeyfbl5747rcqd9y
20 Apr 20
CORPORATE PRESENTATION Frank Bedu-Addo Ph.D. President & CEO APRIL 2020
5:09pm
424B4
c5imu p77c9
12 Feb 20
Prospectus supplement with pricing info
5:22pm